Strategic Direction

Formed in 2004, the Marie Curie Palliative Care Institute Liverpool (MCPCIL) is a partnership between The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Marie Curie and the University of Liverpool.

Strategic Direction

The vision of the Institute is to be an international leader, a collaborative partner and a centre of research excellence for care of the dying. It aims to facilitate and support those who want to make a local, national or international difference to drive up quality for care of the dying.

The Institute is based within the Cancer Research Centre at the University of Liverpool, with clinical sites at the Marie Curie Hospice, Liverpool and the Directorate of Specialist Palliative Care at the Royal Liverpool and Broadgreen University Hospital NHS Trust.

The plurality of the Institute enables it to engage with service providers, research structures and training resources across the three environments in pursuit of the strategic aims of both the institute and its partners.
Through service improvement and innovation, research and development, and learning and teaching, the Institute is making a sustained difference to patient care, from bedside to policy.

The MCPCIL's specific focus on Care of the Dying is unique within world research and necessarily engages a frame of reference beyond care of the dying accordingly, the methodological focus of its interdisciplinary research is broad, engaging studies in basic science and pharmacokinetics, to qualitative psychological and social inquiry. The challenges in generating meaningful scientific evidence in this sensitive area have motivated the Institute to develop novel and innovative research methodologies, often in collaboration with international academic partners.

The Scope of the MCPCIL's Portfolio in Care of Dying

Over the past eight years the Institute has developed expertise both in methodology and the ethical challenges of performing research related to this complex area of care.  As a result, the Institute secured one of only two EU 7th Framework Co-ordination & Support Grants (2008/2011) in Cancer and End of Life Care, "OPCARE9: a European Collaboration to optimise research for the care of cancer patients in the last days of life", was co-ordinated and led by the Institute. It involved over 70 multidisciplinary researchers from 7 European and 2 international partner countries and was worth EURO2.2m. This led to the establishment of an international research collaboration (IORC), led by Professor John Ellershaw where international leaders develop high profile research to improve care of the dying.

Institute Strategic Direction

The Institute strives to respond to and drive the public policy agenda to promote patient choice, dignity and respect through broader societal engagement and working in partnership with local, regional, national and international bodies.  Through its various research and quality improvement projects, the Institute aims to promote safe, effective, patient centred, timely, and efficient, equitable and measurable care at the end of life.   Living and dying well is a core value that informs the work of the Institute, and we believe that good communication, care and compassion are paramount in supporting patients to achieve this goal.  Working collaboratively across Europe and beyond has strengthened our commitment and capacity to undertake high quality, robust research, to utilise service innovation and improvement methodology and knowledge transfer to improve care for the dying in the 21st Century.